NCT05856448Phase 2Completed

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus

Study sponsor: Lakefront Biotherapeutics NV · LKFT

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2025-10-08Actual
Enrollment · participants186Actual
Source updated2026-05-14Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status

Recorded edit
− Previous value

Active not recruiting

+ Updated value

Completed

Check registry source

· 2 fields changed

Completion date type

Recorded edit
− Previous value

Estimated

+ Updated value

Actual

Primary completion date

Recorded edit
− Previous value

2025-10

+ Updated value

2025-10-08

Check registry source